Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
Status:
Withdrawn
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, single-arm trial to evaluate the safety and efficacy of inhaled
treprostinil in subjects with pre-capillary pulmonary hypertension (PH) associated with
Chronic Obstructive Pulmonary Disease (COPD).